Clinical trial · Observational
Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study
NCT06800105CI-TRIAL-00085224recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Minimal information is available regarding changes in whole-body metabolism in ovarian cancer patients, and no study has assessed whole-body lipid metabolism in this patient population. In this pilot study we will assess fasting and postprandial lipid metabolism of ovarian cancer patients before, during, and after treatment via indirect calorimetry.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ovary Cancer | Ovarian Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| High fat smoothie | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Patients with presumed ovarian cancer
- description
- Patients with presumed ovarian cancer will complete three, 4-hour study visits at the following time points: * The 1st visit will occur before treatment. * The 2nd visit will occur after about half of the planned treatment as been completed. * The 3rd visit will occur 4-8 weeks after the completion of treatment.
- interventionNames
- Other: High fat smoothie
Primary outcomes (2)
- measure
- Feasibility assessed by attrition
- timeFrame
- 60 months
- description
- Feasibility assessed by ≤20% attrition (yes/no), defined as the percentage of enrolled participants, that are able to complete all three study visits.
- measure
- Feasibility and acceptability assessed by protocol adherence
- timeFrame
- 60 months
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Women * Age \>18 * Presumed ovarian cancer diagnosis (i.e. those being clinically evaluated for suspicion of ovary cancer) * Planned treatment course for ovarian cancer involving cytoreductive surgery followed by chemotherapy * Availability to commit to attending all study visits * Internet access and consistent access to phone/email/text communication Exclusion Criteria: * Pregnancy * Inability to provide voluntary informed consent * Inability to consume the pre-study visit meal/snack and/or the study visit meal due to strict dietary restrictions * Illicit substance use (e.g. cocaine, methamphetamines, heroin, street drugs) - marijuana and CBD oil and related supplements will be considered on a case-by-case basis by the principal investigators * Circumstances and/or medical condition that would limit compliance with study requirements and protocol, as determined by the principal investigators
References
Publications (0)
Data not yet available
No reference posted for this study.